Active substance
Results for the substance degarelix
2 results
About this active substance
Degarelix is a medication used for the treatment of advanced prostate cancer. It acts as a gonadotropin-releasing hormone (GnRH) antagonist, rapidly reducing testosterone levels, which stimulate the growth of cancer cells.
The medication is administered as subcutaneous injections, usually once a month. It is effective in controlling disease progression and reducing symptoms associated with prostate cancer.
Side effects may include hot flashes, weight gain, fatigue, nausea, and injection site reactions. Regular monitoring of testosterone levels and overall health is essential.
Consult your doctor to discuss the benefits and risks of treatment with Degarelix. Follow all medical recommendations to ensure treatment effectiveness.
The medication is administered as subcutaneous injections, usually once a month. It is effective in controlling disease progression and reducing symptoms associated with prostate cancer.
Side effects may include hot flashes, weight gain, fatigue, nausea, and injection site reactions. Regular monitoring of testosterone levels and overall health is essential.
Consult your doctor to discuss the benefits and risks of treatment with Degarelix. Follow all medical recommendations to ensure treatment effectiveness.